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R. Hultgren,* P. Olofsson and E. WahlbergDepartment of Vascular Surgery, Karolinska Hospital, Stockholm, SwedenObjective. To investigate, in patients treated for critical limb ischemia, how pre-operative conditions, localisation of lesions
and outcome varied according to gender.
Design. Retrospective cohort study.
Methods. Medical records were analysed for all patients treated with vascular reconstruction or PTA for critical limb
ischemia 1993–1994 (119 women, 115 men) at the Karolinska Hospital. All events such as secondary intervention,
amputation and death occurring until 2003 were included in the analysis.
Results. The preoperative conditions were similar between women and men apart from higher mean age (74 years in women
vs 69 in men, pZ0.0002), fewer subjects with a smoking history (63 vs 82%, pZ0–005) and diabetic disease (22 vs 43%,
pZ0.0004) among females. More interventions were performed suprainguinally in women (44% in women vs 19% in
men). Amputation and survival rates were similar in women and men, even after matching for age and diabetes.
Conclusion. Women were older, had a lower frequency of diabetes, smoked less and had more proximal lesions than treated
men. Outcome was identical for both genders. Biological and anatomical differences could possibly explain several of the
found gender differences. Gender differences in risk factors and possibly in the selection process also may have contributed to
our findings.Keywords: Gender differences; Vascular reconstruction; Critical limb ischemia; Lower limb ischemia; Amputation.Introduction
Women with chronic critical limb ischemia (CLI) are
reported to have poorer survival, higher amputation
rate and lower graft patency after revascularisation
than men.1–6 In contrast, women had better survival
and similar amputation rates when age differences
were considered in a previous large registry-based
study on patients treated for lower limb ischemia (LLI)
from the Stockholm area.7 We speculated that this age
difference may be responsible for the varying out-
comes in previous reports. This was supported by
other recent studies using age-adjusted data.8–11
While outcome was almost identical in the former
Stockholm study, we noted that women and men with
lower limb ischemia underwent slightly different
interventions.12 The design of registry-based studies
did not allow detailed analysis of preoperative risk
factors, localisation of treated lesions, technical aspectsing author. Rebecka Hultgren, MD, PhD, Department
urgery, N2:00, Karolinska Hospital, 171 76 Stockholm,
: rebecka.hultgren@kus.se
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cations. Undetectable gender differences may still be
present. Therefore, the purpose of this study was to
identify factors that could influence outcome differ-
ently for women and men with CLI.
We performed a retrospective analysis and long
term follow-up of a well defined group of patients
with CLI treated at our hospital with vascular
reconstruction or PTA within the same time period
as the previous Stockholm study.Patients and MethodsPatients and methods
All vascular or endovascular interventions performed
for arterial occlusive disease in the lower extremity,
defined by ICD 9 codes, at the Karolinska Hospital
1993–1994 were identified by the patients’ individual
registration number. The time period was chosen to
correspond to the Stockholm study and to enable long-
term follow-up.7,12 Medical records for these patientsEur J Vasc Endovasc Surg 29, 295–300 (2005)
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were reviewed and patients having CLI were selected
for inclusion in the study. CLI was defined according
to the TASC document as patients suffering typical
chronic ischemic rest pain, or with ischemic skin
lesions.13 Seven female patients (5%) and five males
(4%) were excluded due to incomplete records, which
left 119 women and 115 men with CLI to analyse. The
local ethics committee at the Karolinska Hospital
approved the study.
All data concerning hospital stay, interventions,
pre- and postoperative visits, amputations, medication
etc from the patients’ charts from the Karolinska
Hospital were recorded.
For each patient only the first leg treated during the
period was included in the study—called ‘ipsilateral
leg’. We analysed all major ipsilateral interventions
and amputations performed during 1993–2003 on
these patients at the Karolinska Hospital.
The information collected was recorded on a data
sheet and analysed at a patient level.
Survival data were obtained and analysed in May
2003 using the hospital data base, which is updated to
the Swedish Cause-of-Death register at the National
Board of Health and Welfare.Definitions
Chest X-ray was performed pre-operatively in 80
women and 76 men, the result was classified according
to the radiologist note as satisfactory, in the absence of
signs of heart failure, heart enlargement or signs of
chronic pulmonary pathology. Body mass index (BMI)
was calculated as the weight (kg)/length2 (m2). The
patient history was considered positive for cardiovas-
cular risk factors if one or more of the following
conditions were listed in the records; angina, myocar-
dial infarction (MI), arrhythmia or congestive heart
failure. Patients with type 1 and type 2 diabetes,
insulin-dependant and non-insulin dependant dia-
betes mellitus, are categorised as diabetic patients.
Length of hospital stay was defined as the number of
days from admission to discharge from our ward.
Analysis of severity of disease was based on the
presence of rest pain, ulcers and gangrene. A vascular
intervention was any major vascular reconstruction or
endovascular procedure. A minor secondary pro-
cedure was defined as a minor surgical procedure,
such as toe exarticulation or ligation of AV fistulas
from a vascular graft. Localisation of lesions treated
was categorised into three groups; suprainguinal
(above the inguinal ligament), femoropoplitealEur J Vasc Endovasc Surg Vol 29, March 2005(below ligament but above knee) and femorodistal
interventions (below the knee joint).
A patient was considered to have a postoperative
infection when a note of wound infection requiring
antibiotic treatment occurred in the records. Post-
operative MI was defined by the presence of elevated
enzymes, ECG-changes that were diagnosed by a
cardiologist as a MI and occurred during the hospital
stay. Postoperative graft occlusion, graft or anastomo-
tic stenosis was recorded when a note of these
complications, verified by a Duplex-scan or physical
examination was found in the patients records. Post-
operative improvement was relief of symptoms or
healing of ulceration when verified in the patient’s
records. All patients amputated ipsilaterally 1993–
2003, with more than a toe exarticulation, were
classified as amputation patients.Clinical practice at the Karolinska Hospital 1993–1994
The radiology department provided high quality
diagnostic angiograms and endovascular interven-
tions during the time period. Access to Duplex
sonography was restricted and could not keep pace
with the increasing number of procedures performed
at that time. Most vascular interventions were per-
formed by a team of at least two surgeons, one
experienced vascular surgeon and one resident. The
graft preference for infrainguinal bypass was auto-
logous vein, PTFE was considered a possible alterna-
tive for above-knee procedures. Below knee
procedures were rarely attempted with synthetic
materials.
Treated patients returned for a 30 days postopera-
tive visit. For patients treated with infrainguinal
recontructions a Duplex scanning was performed.
Most patients also were asked to attend for a 1-year
follow-up visit.Statistics
Comparison of continuous data between women and
men was performed with t test and differences in
categorical data were analysed by c2 analysis. Statisti-
cal significance was defined as a P value less than 0.05.
The time to amputation or death was analysed with
a Cox regression model, considering age, sex, diabetes,
severity of disease (rest pain vs ulcers or gangrene) and
localisation of lesions treated.
The mortality from the date of surgery until 31 April
2003 was also compared with the mortality in the
general population with the same age, by calculating
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observed to expected number of deaths.
A match for age and concomitant diabetes at the
first qualifying intervention was performed in women
and men, with random numbers using the software
Excel (Microsoft). A woman was used as standard,
matching the first man at the same age with the lowest
random number. This resulted in 80 age matched
women and men, median age 74 (47–87) with 22
diabetic women and 22 men.ResultsTable 2. Severity of disease and localisation of arterial lesion at the
qualifying intervention 1993–1994
Women (%) Men (%) PPatient characteristics
Women had a higher mean age at their qualifying
intervention than men (74 vs 70 years). The patients’
characteristics are presented in Table 1. There were
fewer female diabetic patients and smokers, but other
risk factors were similar. The median number of
outpatient visits to the Department of Vascular
Surgery before the intervention and number of
patients admitted for urgent intervention was similar
for women and men.
When women and men were matched for age and
diabetes, the distribution of risk factors were still
similar. Different from direct comparison, the smoking
habits were also the same (69 vs 80%, pZ0.32). An
equal proportion of women and men had rest pain at
the qualifying intervention, in the unmatched and
matched group (Table 2).Table 1. Patient characteristics
Women n (%)
nZ119
Men n (%)
nZ115
P
Mean age at first
intervention
74.0 (47–92) 69.4 (45–87) 0.0002*
Married or widowed 84 (71) 74 (64)
Living at home 102 (86) 104 (90) 0.23
Smoking before or now 75 (63) 94 (82) 0.005
Pulmonary X-ray
satisfactory
69 64 0.92
BMI (kg/m2) 23.7 (14–36) 23.5 (16–35) 0.83*
Angina 30 (25) 30 (26) 0.62
Hypertension 62 (52) 56 (49) 0.87
MI 25 (21) 27 (23) 0.79
By pass/ptca 7 (6) 6 (5) 0.37
CVL 18 (15) 26 (23) 0.16
Arrhythmia 28 (23) 26 (23) 0.98
Heart failure 36 (30) 34 (29) 0.99
No cardiovascular risk
factor
53 (44) 48 (42) 0.90
Malignancy 22 (18) 13 (11) 0.19
Diabetes 26 (22) 50 (43) 0.0004
c2 analysis used for all categorical data.
* t-test is used for continuos data.Localisation of lesions treated
The localisation of the treated lesions differed between
women and men, more suprainguinal were treated in
women (44% in women vs 19% in men) (Table 2).
This gender difference remained after matching for
age and diabetes, and was found both for surgical
interventions and PTA (Table 2).
When all ipsilateral interventions performed on
these patients in 1993–2003 were analysed, again there
were more suprainguinal lesions in women (40% in
women vs 22% in men, pZ0.02). In 92% of the open
vascular reconstructions used bypass grafts, autolo-
gous veins more often in men than in women (Table 2).Outcome
Most measured outcome variables, such as mortality
and amputation rates, were similar in women and men
over time. The number of amputations in women and
men was also similar in the matched subgroup (11/80
vs 8/80, pZ0.48) (Table 3). Forty-three women (36%)
and 44 men (38%) were treated more than once in the
same leg during the period 1993–2003. Minor second-
ary procedures were performed in a similar pro-
portion of women and men. Postoperative bleeding
was similar (5 vs 5%, pZ0.82), but infection tended to
be more common in men (7 vs 12%, pZ0.08). FournZ119 nZ115
Severity of disease
Rest pain 55 (46) 51 (44) 0.77*
Ulcer or gangrene 64 (54) 64 (56)
Surgery† 72 75
Suprainguinal 14 (19) 2 (3) 0.004*
Infrainguinal-above
knee
26 (36) 29 (39)
Below knee 32 (44) 44 (59)
Mean age (range) 75 (47–92) 70 (45–87)
Autologous vein 37 (51) 51 (68) 0.06
PTA† 47 40
Suprainguina 39 (83) 20 (50) 0.004*
Infrainguinal—above
knee
7 (15) 17 (42)
Below knee 1 (2) 3 (8)
Mean age (range) 72 (50–87) 68 (51–87)
All vascular ipsilateral
interventions 1993–2003
191 173 0.86*
Patients treated contra-
lateral leg 1993–2003
24 (20) 31 (27) 0.68
Number of patients (percent) is presented.
* Differences in the distribution of suprainguinal intervention,
above knee and below knee between women and men were tested
with c2.
† Overall c2 analysis for the number of PTA and vascular
reconstructions for women and men showed no difference, pZ0.46.
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(pZ0.05). Length of hospital stay was 11 days for
women (0–37) and 9 days for men (0–59), pZ0.19.
The frequency of postoperative graft occlusion (19
vs 16%, pZ0.35) and anastomotic or graft stenosis (5 vs
8%, pZ0.27) were also similar. One year after the
qualifying intervention more men had improved, but
less women attended the clinical follow-up and were
available for analysis (51% of women vs 35% of men)
(Table 3).
The number of interventions preceding an amputa-
tion was not different for women and men. The time to
amputation was not significantly affected by age,
localisation of lesion, gender or diabetes. No corre-
lation was found between the localisation of lesion and
amputation in matched patients (pZ0.33 for women,
pZ0.24 for men).
Time to death, after surgery, for all patients and the
matched subgroup was influenced only by age (Cox
regression model pZ0.004). No correlation between
survival and localisation of lesions treated was found
for women or men in the matched group (pZ0.60, pZ
0.07). Using a calculation of standardised mortality
ratio (SMR), an excess mortality was observed for the
CLI patients, 174 deceased patients compared to the
estimated 62 persons (SMR 2.53, CI 2.16–2.93). A
higher SMR was found in males, smokers, diabetic
patients and patients with one or more cardiovascular
risk factor (Table 4).Discussion
This study support observations that outcome after
vascular interventions for CLI are similar in womenTable 3. Postoperative mortality
Dead n (%) P Amputated
n (%)
P
30 days
Women 2 (2) 0.08 1 (2) 0.35
Men 7 (6) 4 (4)
1 year
Women 17 (14) 0.32 7 (7) 0.47
Men 22 (19) 9 (10)
5 years
Women 62 (52) 0.34 5 (9) 0.94
Men 67 (58) 4 (8)
May 2003
Women 88 (74) 0.34 1 (3) 0.14
Men 85 (74) 4 (13)
The number of amputated patients, second interventions and improve
patients alive. Outcome for all patients alive in May 2003 (9–10 years p
* Minor secondary procedures or major vascular intervention.
† Missing patients, but alive; 52 women (51%) and 33 men (35%), p!
‡ No standardised clinical follow-up after 1 year.
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in spite of rather striking differences in age, smoking
habits and presence of diabetes. Moreover women and
men appear to be treated for lesions in different
localisations.
The high proportion of women in this report,
compared to most other studies, is probably related
to differences in the studied populations. We chose to
include only patients with CLI while other reports are
based on the type of intervention performed, without
considering the indication.4,8,10,14,15
A possible explanation for the higher mean age
observed in women is delayed diagnosis, which was
supported by a prevalence study of LLI patients and
by the reported higher number of women with ulcers
and gangrene preoperatively compared to men.1,3,5,14
This is not supported by our study, where the
frequency of rest pain and ulcers at presentation was
identical, in spite of the age difference.
A later onset of disease is a plausible reason for the
age difference between women and men, as has been
shown for coronary heart disease. Protection by
endogenous oestrogen could hypothetically explain
the higher mean age in women treated for CLI.16
The only difference in cardiovascular risk factors in
this study were the prevalence of diabetes and
smoking. Among Swedes, the prevalence of diabetes
is 5% in women and 6% in men.17 It is not likely that
the lower frequency in our women is due to the low
prevalence in the female population in general. The
share of patients having diabetes when undergoing
vascular interventions varies greatly (24–59%) and in
most studies more female patients have diabetes than
men.3,5,6,10,18–20 The report of less diabetes among
women, has to our knowledge only been reported onceSecond
intervention*
n (%)
P Improvement
n (%)
P
28 (24) 0.64 88 (74) 0.93
23 (21) 84 (73)
42 (41) 0.61 35 (34)† 0.001
35 (38) 53 (57)†
29 (51) 0.17 ‡ ‡
18 (38)
19 (61) 0.25 –‡ –‡
14 (47)
ment 30 days, 1 year and 5 years after the qualifying intervention of
ostoperatively) is also presented.
0.001.
Table 4. Observed mortality for treated patients compared with expected mortality (SMR)
Expected Observed SMR CI
All patients 62 174 2.8 2.4–3.25
Gender Female 36 89 2.4 2.0–3.0
Male 26 85 3.3 2.6–4.1
Diabetes Yes 13 58 4.6 3.5–5.9
No 56 116 2.3 1.9–2.8
Smoking Yes 37 121 3.3 2.7–3.9
No 30 62 2.0 1.6–2.6
Cardiovascular risk factor Yes 32 112 3.5 2.9–4.3
No 35 62 1.8 1.36–2.27
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it has been shown that 40% of MI patients were
reported to suffer from undiagnosed impaired glucose
tolerance, but it is unlikely that this underestimation
would be more common in women.22 Another
explanation for the low prevalence of diabetes
among our women could be negative selection of
women with diabetes. Women often have smaller
vessels than men, and patients with diabetes tend to
have worse run-off. This combination may have
caused ‘rejection’ for surgical intervention. Such
negative selection has been observed by others.20,23
Smoking also appeared to be less frequent among
our women, supporting the statement that we treated
women with less risk factors than men. Data on
smoking habits, however, are known to be unreliable
in retrospective studies of this kind.
The number of vascular interventions and PTAs
were equal in women and men, but women under-
went more suprainguinal interventions than men. Was
the first suprainguinal intervention in women only a
procedure to improve ‘inflow’ prior to an infrainguinal
intervention? No, since the high percentage of
suprainguinal interventions performed on the ipsilat-
eral leg was similar for women both when only the
first intervention 1993–1994 (44%) or the total number
of interventions 1993–2003 (40%) were analysed: this
also was observed for men(19 vs 22%). This gender
difference has to our knowledge not been reported
previously. One explanation is methodological differ-
ences, another could be lack of a gender perspective
when data from endovascular procedures are pre-
sented.24–26 There also might be a selection bias due to
poor anatomical conditions in women (more distal
lesions, smaller lumen areas and lack of veins for
grafting).11 It is possible that gender differences in the
localisation of treated lesions has disappeared since
1994, due to better angiography and surgical
techniques.
In our report outcome variables were similar for
women and men with the exception of postoperative
MI, as has been reported by others.4,8 The numberswere small in our study and should be interpreted
with caution. Less women were considered improved
at follow-up, this is not in line with the similar graft
occlusion rates nor the equal number of interventions
and amputations among women and men. The low
number of women who attended the 1-year follow-up
could explain the observed difference in perceived
outcome. Women who still had problems may have
been more inclined to return to the clinic after 1 year.
As in other reports, amputation rates were also
similar for women and men.1,4,8,10,11,21 The previous
notion that female gender is a risk factor for amputa-
tion is probably due to a misconception of ‘female
gender’ as a risk factor per se: high age, diabetic disease
and more severe symptoms are more commonly found
in women.
Similar to other recent studies, we did not find a
gender difference in survival rates.8,10,11,21 Compared
to the general population survival in our patients was
poor, treated women have an excess mortality com-
pared to the normal population, but not compared
with treated men.
It is possible that the more frequent suprainguinal
interventions in women, with possibly better outcome,
could explain the almost identical outcome in women
and men. It is possible that women might have had
worse outcome if the location of disease was the same
as in men. However, we found no influence on
outcome by the level of disease in our regression
model or in patients matched for age and diabetes.Conclusion
At the Karolinska Hospital women treated for CLI in
1993–1994 were older, had a lower frequency of
diabetes, smoked less and had more proximal lesions
than treated men.
Outcome was almost identical for both genders.
Biological and anatomical differences can probably
explain several of the found gender differences, as well
a different distribution of risk factors. Differences inEur J Vasc Endovasc Surg Vol 29, March 2005
R. Hultgren et al.300the selection process for women and men also may
have contributed to our findings.Acknowledgements
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